Anthrax Vaccine Maker Given New Contract Worth Millions

By: News 10
By: News 10

Emergent Bioslutions has been awarded a contract worth up to $186.5 million dollars to devlop the next generation of anthrax vaccine for the federal government.

The contract is with the Department of Health and Human Services for the development of a recombinant protective antigen anthrax vaccine.

Company Spokesman Mark Alley says the new contract will mean an additional 25 jobs at the Lansing plant.

Emergent Chairman and chief executive officer Fuad El-Hibri says the new agreement "solidifies Emergent's anthrax francise and reaffirms our position as the leading supplier to, and developer for, the U.S. government of anthrax biomedical countermeasures."

WILX 500 American Road Lansing, MI 48911 517-393-0110
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 103155724 -
Gray Television, Inc.